AMGEN INC — Investor Relations & Filings
Amgen Inc. is a multinational biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. As a pioneer in the field, the company utilizes advanced science and technology, including genetics and molecular engineering, to create biologic medicines from living cells. Amgen's portfolio and pipeline target serious illnesses with limited treatment options across key therapeutic areas, including oncology, cardiovascular disease, inflammation, bone health, and neuroscience. The company's mission is to translate scientific promise into therapies that restore health and improve the lives of patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-20 | English | |
| 8-K | 2026-05-19 | English | |
| 10-Q | 2026-05-01 | English | |
| 8-K | 2026-04-30 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 8-K - AMGEN INC (0000318154) (Filer) | 2026-04-22 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46693267 | 8-K | 2026-05-20 | English | ||
| 46556601 | 8-K | 2026-05-19 | English | ||
| 46067890 | 10-Q | 2026-05-01 | English | ||
| 46067921 | 8-K | 2026-04-30 | English | ||
| 46067927 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 35389212 | 8-K - AMGEN INC (0000318154) (Filer) | 2026-04-22 | English | ||
| 46067939 | DEFA14A | 2026-04-21 | English | ||
| 46067948 | DEFA14A | 2026-04-15 | English | ||
| 46067959 | DEFA14A | 2026-04-07 | English | ||
| 33744736 | DEF 14A - AMGEN INC (0000318154) (Filer) | 2026-04-07 | English | ||
| 33115775 | ARS - AMGEN INC (0000318154) (Filer) | 2026-03-31 | English | ||
| 33051847 | SCHEDULE 13G/A - AMGEN INC (0000318154) (Subject) | 2026-03-26 | English | ||
| 32981280 | 4 - AMGEN INC (0000318154) (Issuer) | 2026-03-19 | English | ||
| 32981231 | 4 - AMGEN INC (0000318154) (Issuer) | 2026-03-19 | English | ||
| 32981226 | 4 - AMGEN INC (0000318154) (Issuer) | 2026-03-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
AMGEN INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29819/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29819 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29819 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29819 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29819}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AMGEN INC (id: 29819)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.